InsiderTrades

Form 4 for LH Labcorp

Accepted 2023-02-07 00:00:00 ET · period of report 2023-02-04 · accession 0001127602-23-003710 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-07 2023-02-06 LH Schechter Adam H Pres, CEO, Dir F - Tax $244.50 -1,368 21.7K -6% -$334.5K
D 2023-02-07 2023-02-04 LH Schechter Adam H Pres, CEO, Dir M - OptEx — +3,507 23.1K +18% —
D 2023-02-07 2023-02-04 LH Schechter Adam H Pres, CEO, Dir M - OptEx $0.00 -3,507 10.7K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-06 F D 1,368 $244.50 21,695 D — —
2 Common Common Stock 2023-02-04 M A 3,507 — 23,063 D — — (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
3 Derivative Restricted Stock Unit 2023-02-04 M D 3,507 $0.00 10,744 D — · — to — 3,507 Common Stock (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F3) The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.